Company Filing History:
Years Active: 2003
Title: Jon T Holmlund: Innovator in Protein Kinase C Research
Introduction
Jon T Holmlund is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein kinase C research. His work focuses on developing therapeutic methods for diseases associated with this important protein.
Latest Patents
Holmlund holds a patent titled "Oligonucleotide inhibition of protein kinase C." This patent describes compositions and methods for the treatment and diagnosis of diseases linked to protein kinase C. The invention includes oligonucleotides that target nucleic acids encoding PKC. In preferred embodiments, these oligonucleotides contain one or more chemical modifications. The patent also discloses methods for modulating PKC expression and treating animals suffering from diseases that can be addressed by altering protein kinase C expression using these targeted oligonucleotides. He has 1 patent to his name.
Career Highlights
Holmlund is associated with Isis Pharmaceuticals, Inc., a company known for its innovative approaches in the field of drug development. His work at the company has contributed to advancements in therapeutic interventions for various diseases.
Collaborations
Throughout his career, Holmlund has collaborated with notable colleagues, including C Frank Bennett and Nicholas M Dean. These collaborations have further enhanced the research and development efforts in the field of protein kinase C.
Conclusion
Jon T Holmlund is a distinguished inventor whose work in protein kinase C research has the potential to impact the treatment of various diseases. His contributions through patents and collaborations highlight his commitment to advancing biotechnology.